7 glutathione and is transporters in ocular surface defense Its Frontiers | Astaxanthin activated the
Frontiers Astaxanthin activated the SLC7A11 GPX4 pathway to inhibit ferroptosis and enhance autophagy, ameliorating dry eye disease In defence of ferroptosis Signal Transduction and Targeted Therapy Nanotechnology based ocular drug delivery systems: recent advances and future prospects PMC Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis Cell Death & Disease Deficiency in glutathione peroxidase 4 (GPX4) results in abnormal lens development and newborn cataract PNAS
Pay in 4 interest-free payments of $5.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




